| Literature DB >> 36064875 |
Sebastian Hartmann1, Anna Lang2, Sara Lener2, Anto Abramovic2, Lukas Grassner2, Claudius Thomé2.
Abstract
Instrumented stabilization with intersomatic fusion can be achieved by open (O-TLIF) or minimally invasive (MIS-TLIF) transforaminal surgical access. While less invasive techniques have been associated with reduced postoperative pain and disability, increased manipulation and insufficient decompression may contradict MIS techniques. In order to detect differences between both techniques in the short-term, a prospective, controlled study was conducted. Thirty-eight patients with isthmic or degenerative spondylolisthesis or degenerative disk disease were included in this prospective, controlled study (15 MIS-TLIF group vs. 23 O-TLIF group) after failed conservative treatment. Patients were examined preoperatively, on the first, third, and sixth postoperative day as well as after 2, 4, and 12 weeks postoperatively. Outcome parameters included blood loss, duration of surgery, pre- and postoperative pain (numeric rating scale [NRS], visual analog scale [VAS]), functionality (Timed Up and Go test [TUG]), disability (Oswestry Disability index [ODI]), and quality of life (EQ-5D). Intraoperative blood loss (IBL) as well as postoperative blood loss (PBL) was significantly higher in the O-TLIF group ([IBL O-TLIF 528 ml vs. MIS-TLIF 213 ml, p = 0.001], [PBL O-TLIF 322 ml vs. MIS-TLIF 30 ml, p = 0.004]). The O-TLIF cohort showed significantly less leg pain postoperatively compared to the MIS-TLIF group ([NRS leg 3rd postoperative day, p = 0.027], [VAS leg 12 weeks post-op, p = 0.02]). The MIS group showed a significantly better improvement in the overall ODI (40.8 ± 13 vs. 56.0 ± 16; p = 0.05). After 3 months in the short-term follow-up, the MIS procedure tends to have better results in terms of patient-reported quality of life. MIS-TLIF offers perioperative advantages but may carry the risk of increased nerve root manipulation with consecutive higher radicular pain, which may be related to the learning curve of the procedure.Entities:
Keywords: MIS techniques; MIS-TLIF; Spondylolisthesis
Mesh:
Year: 2022 PMID: 36064875 PMCID: PMC9492567 DOI: 10.1007/s10143-022-01845-w
Source DB: PubMed Journal: Neurosurg Rev ISSN: 0344-5607 Impact factor: 2.800
Exclusion criteria
| Exclusion criteria |
|---|
| Previous surgery (instrumented lumbar spinal surgery, cervical and/or thoracic spinal disease) to the extent that surgical consideration is likely or anticipated within 6 months after the lumbar surgical treatment |
| Other degenerative joint diseases (i.e., shoulder, hip knee) to the extent that surgical consideration is likely or anticipated within 6 months after or before the lumbar surgical treatment |
| Other physical diseases (e.g., neuromuscular disorders) before and/or within 6 months after lumbar surgical intervention which are able to restrict study procedures (i.e., wheelchair bound) |
| Neoplasia as the source of symptoms fixed or permanent neurological deficit, unrelated to the lumbar spine disease |
| Active or chronic infection, systemic or local (including HIV, AIDS, hepatitis) |
| Active malignancy defined as a history of any invasive malignancy, except non-melanoma skin cancer, unless the patient has been treated with curative intent and there have been no clinical signs or symptoms of the malignancy for a minimum of 5 years |
| Autoimmune disorder that impacts the musculoskeletal system (i.e., lupus, rheumatoid arthritis, ankylosing spondylitis) |
| Acute episode or major mental illness (psychosis, major affective disorder, or schizophrenia) |
| Physical symptoms without a diagnosable medical condition to account for the symptoms, which may indicate symptoms of psychological rather than physical origin |
| Recent or current history of substance abuse (drugs, alcohol, narcotics, recreational drugs) |
| Known allergy to titanium |
| 3 or more vertebral levels requiring surgical treatment in the lumbar spine and clinically compromised vertebral bodies at the affected level due to current or past trauma (including osteoporotic fractures) |
Demographic details of the patient cohort
| Group O, | Group MIS, | |||
|---|---|---|---|---|
| Age | In years (SD) | 59.1 (± 12.6) | 53.7 (± 8.7) | n.s |
| Sex, | Male | 5 (21.7) | 4 (26.7) | n.s |
| Female | 18 (78.3) | 11 (73.3) | ||
| BMI | In kg/m2 (SD) | 28.9 (4.9) | 28.7 (4.8) | n.s |
| ASA score, | °1 | 4 (17.4) | 3 (20.0) | n.s |
| °2 | 13 (59.1.) | 7 (46.7) | ||
| °3 | 4 (17.4) | 5 (33.3) | ||
| °4 | 1 (4.3) | 0 (0.0) | ||
| Smoking, | 9 (39.1) | 9 (64.3) | n.s | |
| Treatment indication, | Osteochondrosis | 5 (21.7) | 6 (40.0) | n.s |
| Degenerative spondylolisthesis | 12 (52.2) | 3 (20.0) | ||
| Isthmic spondylolisthesis | 6 (26.1) | 6 (40.0) | ||
| Treatment level, | L4/5 | 13 (56.5) | 10 (66.7) | n.s |
| L5/S1 | 7 (30.4) | 5 (33.4) | ||
| Bi-segmental | 3 (13.0) | 0 (0.0) | ||
| Duration of surgery | In minutes (SD) | 197.9 (± 53.7) | 179.0 (± 46.1) | n.s |
| Loss of blood | Intraoperative, ml (SD) | 527.6 (± 315.1) | 212.6 (± 178.1) | 0.001 |
| Postoperative, ml (SD) | 321.5 (± 351.7) | 30.0 (± 94.9) | 0.004 | |
| Intraoperative complications, | Accidental durotomy | 2 (8.7) | 1 (6.7) | n.s |
n population, SD standard deviation, Group O open surgical procedure, Group MIS minimally invasive surgery, ASA American Society of Anesthesiologists Score, BMI body mass index, n.s. not statistically significant
Fig. 1Valuation of pre- and postoperative VAS back and VAS leg. (O: open surgical procedure, MIS: minimally invasive surgery)
Fig. 2Valuation of pre- and postoperative NRS back and NRS leg. (O: open surgical procedure, MIS: minimally invasive surgery)
Fig. 3Valuation of pre- and postoperative Timed Up and Go (TUG) test for functional gait assessment. (O: open surgical procedure, MIS: minimally invasive surgery)
Overview of the patient-reported outcome measures (PROMs)
| Pre | Pre - 6 days | 6 days | 6 d - 2 w | 2 weeks | 2 w - 4 w | 4 weeks | 4 w - 12 w | 12 weeks | Pre - 12 w | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| O | MIS |
| O | MIS | O | MIS |
| O | MIS | O | MIS |
| O | MIS | O | MIS |
| O | MIS | O | MIS |
| O | MIS | |
| Δ p | Δ p | Δ p | Δ p | Δ p | Δ p | Δ p | Δ p | Δ p | Δ p | ||||||||||||||||
| ODI sum | 47.6 ± 19 | 38.5 ± 12 |
|
|
| 49.5 ± 18 | 44.3 ± 13 |
|
|
| 56.0 ± 16 | 40.8 ± 13 |
|
|
| 39.8 ± 22 | 33.6 ± 13 |
|
|
| 22.0 ± 23 | 26.0 ± 13 |
|
|
|
| EQ-5D-TTO | 0.58 ± 0.3 | 0.51 ± 0.3 |
|
|
| 0.55 ± 0.3 | 0.47 ± 0.2 |
| n.s. | n.s. | 0.67 ± 0.3 | 0.54 ± 0.2 |
|
|
| 0.75 ± 0.2 | 0.61 ± 0.2 |
|
|
| 0.85 ± 0.2 | 0.68 ± 0.2 |
|
|
|
| EQ-5D-VAS | 0.61 ± 0.4 | 0.58 ± 0.3 |
|
|
| 0.62 ± 0.3 | 0.61 ± 0.3 |
|
|
| 0.76 ± 0.2 | 0.66 ± 0.3 |
|
|
| 0.84 ± 0.2 | 0.73 ± 0.2 |
|
|
| 0.86 ± 0.2 | 0.76 ± 0.3 |
|
|
|
| Health status | 43.0 ± 23 | 49.2 ± 19 |
|
|
| 51.1 ± 22 | 52.8 ± 22 |
|
|
| 64.7 ± 24 | 54.8 ± 22 |
|
|
| 70.0 ± 27 | 66.0 ± 26 |
|
|
| 79.1 ± 25 | 63.8 ± 28 |
|
|
|
| GDS | 3.7 ± 4 | 4.6 ± 3 |
|
|
| 3.0 ± 2.9 | 4.4 ± 2.7 |
|
|
| 2.9 ± 3.6 | 3.4 ± 2.6 |
|
|
| 2.3 ± 3 | 3.7 ± 2 |
|
|
| 2.3 ± 3 | 2.9 ± 3 |
|
|
|
| COMI back | 6.2 ± 2 | 5.5 ± 3 |
|
|
| 5.2 ± 2 | 5.6 ± 2 |
|
|
| 3.6 ± 2 | 3.9 ± 2 |
|
|
| 2.4 ± 2 | 4.1 ± 2 |
|
|
| 2.4 ± 2 | 3.2 ± 2 |
|
|
|
| COMI leg | 6.3 ± 3 | 5.3 ± 2 |
|
|
| 4.3 ± 3 | 3.8 ± 2 |
|
|
| 2.5 ± 3 | 2.5 ± 2 |
|
|
| 1.9 ± 2.3 | 3.4 ± 3 |
|
|
| 1.7 ± 2 | 3.2 ± 2 |
|
|
|
| PBI | 98.3 ± 4 | 98.0 ± 5 |
|
|
| 90.0 ± 13 | 93.9 ± 8 |
|
|
| 95.8 ± 6 | 95.4 ± 6 |
|
|
| 98.9 ± 3 | 97.1 ± 6 |
|
|
| 98.8 ± 3 | 98.9 ± 3 |
|
|
|
ODI sum Oswestry Disability Index summary, EQ-5D-TTO time trade-of valuation, EQ-5D-VAS visual analog scale valuation, GDS geriatric depression scale, COMI-back, -leg Core Outcome Measures Index for the back and leg, PBI Performance-based Barthel Index, n.s. not statistically significant, d day, w week